FIRMQUARRYResearch workspace

GOVERNMENT CONTRACT / PURCHASE ORDER

PURCHASE ANTI-ANTHRAX TOXIN ANTIBODY, RAXIBACUMAB, IN A SINGLE GLASS VIAL AT THE CONCENTRATION OF 10 MG/ML.

Awarded to LIFE TECHNOLOGIES CORPORATION

PIID 75F40123P00450US · USAspendingOther
$17.5K
Data last updated Oct 22, 2026 · Source: USAspending
Transaction obligation$17,500sum disclosed on award record
Current contract valueNot reportednot interchangeable with obligation
Potential contract valueNot reportedincluding options if reported
Award dateSep 25, 2023
Company legal name
LIFE TECHNOLOGIES CORPORATION
UEI / CAGE
JXAKAG32BVN4 / Not reported
Parent award
Not reported
Awarding agency
Department of Health and Human Services
Subagency
Food and Drug Administration
Industry
Other
NAICS
325413
PSC
6505
Performance period
Not reported — Not reported
Recipient address
3175 STALEY RD, GRAND ISLAND, ERIE, NY, 14072
Place of performance
SILVER SPRING, MONTGOMERY, MD, 20993
Source last modified
Nov 2, 2026

Description

PURCHASE ANTI-ANTHRAX TOXIN ANTIBODY, RAXIBACUMAB, IN A SINGLE GLASS VIAL AT THE CONCENTRATION OF 10 MG/ML.

View federal source ↗

Derived from official transactions

Contract lifecycle

  1. Award announced

    PURCHASE ANTI-ANTHRAX TOXIN ANTIBODY, RAXIBACUMAB, IN A SINGLE GLASS VIAL AT THE CONCENTRATION OF 10 MG/ML.

    US · usaspendingSource ↗
  2. Value increased

    PURCHASE ANTI-ANTHRAX TOXIN ANTIBODY, RAXIBACUMAB, IN A SINGLE GLASS VIAL AT THE CONCENTRATION OF 10 MG/ML.

    US · usaspending$17.5KSource ↗

Point-in-time model

Contract change outlook

Predictive intelligenceInsufficient historyNo eligible point-in-time model has produced a prediction for this record.

Uncollapsed source history

Transactions and modifications

Action dateModificationAction typeExact obligationCurrent totalPotential totalDescriptionSource
Sep 25, 20230Not reported$17,500.00Not reportedNot reportedPURCHASE ANTI-ANTHRAX TOXIN ANTIBODY, RAXIBACUMAB, IN A SINGLE GLASS VIAL AT THE CONCENTRATION OF 10 MG/ML.USAspending ↗